
Edward M Peres MD
Hematologic Oncology
Associate Professor Hematology Oncology Stem CellTransplant, Cellular Therapy Internal Medicine, Henry Ford Hospital Wayne State Universty
Join to view full profile
2799 W Grand BlvdSte K13Detroit, MI 48202
Phone+1 313-916-5002
Dr. Peres is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Detroit Medical CenterBone Marrow Transplant , 2003 - 2004
Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2000 - 2003
Children's Hospital of MichiganResidency, Pediatrics, 1997 - 2000
Ross University School of MedicineClass of 1997
Certifications & Licensure
MI State Medical License 2000 - 2028
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity RIS-IC, GE Healthcare, 2015-2017
- CMS Meaningful Use Stage 1 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2015-2017
Clinical Trials
Publications & Presentations
PubMed
- Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant.Kristen L Votruba, Michelle Rozwadowski, Thomas Braun, April Rahrig, Edward Peres
Pediatric Blood & Cancer. 2026-06-01 - 1 citationsCiprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial.Shatha Farhan, Izabela Mazur, Susan Hartzell, Peter Xie, Klodiana Neme
International Journal of Infectious Diseases. 2024-10-01 - 11 citationsOptimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood TransplantScott R. Solomon, Andrew St. Martin, Mei-Jie Zhang, Karen K. Ballen, Asad Bashey
Biology of Blood and Marrow Transplantation. 2020-10-01
Press Mentions
Henry Ford Cancer Institute Treats Its First Patient with Innovative 'Living Drug' TherapyJune 18th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









